Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease.
McIntosh E, Kent S, Gray A, Clarke CE, Williams A, Jenkinson C, Ives N, Patel S, Rick C, Wheatley K, Gray R; PD MED Collaborative Group.
McIntosh E, et al. Among authors: rick c.
Mov Disord. 2021 Sep;36(9):2136-2143. doi: 10.1002/mds.28623. Epub 2021 May 7.
Mov Disord. 2021.
PMID: 33960511
Free article.
Clinical Trial.